Journal editors question sale of diet pill Meridia

Question of the Day

Should Congress make English the official language of the U.S.?

View results

The drug, also known as sibutramine, is sold under a variety of names around the world.

An FDA advisory panel will review the study at a Sept. 15 meeting, while the next day it will consider approval of a new weight-loss drug, lorcaserin. Drugmakers have struggled to come up with a pill that doesn’t have risky side effects. The panel voted against another experimental diet drug in July because of its side effects.

___

Online:

New England Journal: http://www.nejm.org

Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Comments
blog comments powered by Disqus
TWT Video Picks